CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ONCORNET aims to investigate the role of specific receptors in cancer progression, focusing on G protein-coupled receptors. The project seeks to develop tools for diagnostics and therapeutics while training early-stage researchers in drug discovery.
Cancer is a leading health concern.
There is a need to fully understand the fundamental processes underlying development of cancer.
There is increasing evidence that G protein-coupled receptors (GPCRs) and their associated signalling cascades are involved in both cancer progression and metastasis.
As oncogenic GPCRs are likely to be amenable to manipulation via drugs they are ideal therapeutic targets.
In ONCORNET (Oncogenic Receptor Network of Excellence and Training) we propose to target two o…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Nottingham
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Glasgow
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Wuerzburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
